CLINICAL_TRIALS
trial_result
· 2019-10-23
Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008) [Phase 2]
Summary
Phase 2 trial evaluating two lots of V114 in healthy infants to assess safety, tolerability, and immunogenicity has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2019-10-23